ACS Publications. Most Trusted. Most Cited. Most Read
My Activity

Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo

View Author Information
† § Division of NanoMedicine, Department of Medicine, Department of Chemistry & Biochemistry, and §California NanoSystems Institute, University of California, Los Angeles
*Address correspondence to [email protected]
Cite this: ACS Nano 2013, 7, 2, 994–1005
Publication Date (Web):January 4, 2013
Copyright © 2013 American Chemical Society

    Article Views





    Other access options
    Supporting Info (1)»


    Abstract Image

    We used a multifunctional mesoporous silica nanoparticle (MSNP) carrier to overcome doxorubicin (Dox) resistance in a multidrug resistant (MDR) human breast cancer xenograft by codelivering Dox and siRNA that targets the P-glycoprotein (Pgp) drug exporter. The Pgp siRNA selection from among a series of drug resistance targets was achieved by performing high throughput screening in a MDR breast cancer cell line, MCF-7/MDR. Following the establishment of a MCF-7/MDR xenograft model in nude mice, we demonstrated that a 50 nm MSNP, functionalized by a polyethyleneimine–polyethylene glycol (PEI-PEG) copolymer, provides protected delivery of stably bound Dox and Pgp siRNA to the tumor site. The effective biodistribution and reduced reticuloendothelial uptake, as a result of our nanocarrier design, allowed us to achieve an 8% enhanced permeability and retention effect at the tumor site. Compared to free Dox or the carrier loaded with either drug or siRNA alone, the dual delivery system resulted in synergistic inhibition of tumor growth in vivo. Analysis of multiple xenograft biopsies demonstrated significant Pgp knockdown at heterogeneous tumor sites that correspond to the regions where Dox was released intracellularly and induced apoptosis. We emphasize that the heterogeneity originates in the tumor microenvironment, which influences the vascular access, rather than heterogeneous Pgp expression in the MDR cells. Taken together, these data provide proof-of-principle testing of the use of a dual drug/siRNA nanocarrier to overcome Dox resistance in a xenograft. The study also provides the first detailed analysis of the impact of heterogeneity in the tumor microenvironment on the efficacy of siRNA delivery in vivo.

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.


    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Supporting Information

    Jump To

    Additional figures, table, results, and method descriptions as described in the text. This material is available free of charge via the Internet at

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:

    Cited By

    This article is cited by 481 publications.

    1. Elisabeth Eckenberger, Theodor Raczka, Winfried Neuhuber, Luitpold V. R. Distel, Stefanie Klein. Acriflavine-Functionalized Silica@Manganese Ferrite Nanostructures for Synergistic Radiation and Hypoxia Therapies. ACS Applied Bio Materials 2023, 6 (8) , 3089-3102.
    2. Shuwen Dong, Zhenhan Feng, Runpu Ma, Tianyu Zhang, Jinhong Jiang, Yibo Li, Yumo Zhang, Silu Li, Xiao Liu, Xiangsheng Liu, Huan Meng. Engineered Design of a Mesoporous Silica Nanoparticle-Based Nanocarrier for Efficient mRNA Delivery in Vivo. Nano Letters 2023, 23 (6) , 2137-2147.
    3. Mohamed Alaa Mohamed, Lingyue Yan, Aref Shahini, Nika Rajabian, Amin Jafari, Stelios T. Andreadis, Yun Wu, Chong Cheng. Well-Defined pH-Responsive Self-Assembled Block Copolymers for the Effective Codelivery of Doxorubicin and Antisense Oligonucleotide to Breast Cancer Cells. ACS Applied Bio Materials 2022, 5 (10) , 4779-4792.
    4. Haizhou Zhao, Hei Yuen Wong, Danyang Ji, Kaixin Lyu, Chun Kit Kwok. Novel L-RNA Aptamer Controls APP Gene Expression in Cells by Targeting RNA G-Quadruplex Structure. ACS Applied Materials & Interfaces 2022, 14 (27) , 30582-30594.
    5. André E. Nel, Kuo-Ching Mei, Yu-Pei Liao, Xiangsheng Liu. Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs. ACS Nano 2022, 16 (4) , 5184-5232.
    6. Suman Bishnoi, Anshu Kumari, Sheeba Rehman, Aliva Minz, Shantibhusan Senapati, Debasis Nayak, Sharad Gupta. Fusogenic Viral Protein-Based Near-Infrared Active Nanocarriers for Biomedical Imaging. ACS Biomaterials Science & Engineering 2021, 7 (7) , 3351-3360.
    7. Xiufeng Ju, Haiyan Chen, Tongtong Miao, Jiang Ni, Liang Han. Prodrug Delivery Using Dual-Targeting Nanoparticles To Treat Breast Cancer Brain Metastases. Molecular Pharmaceutics 2021, 18 (7) , 2694-2702.
    8. Renye Yue, Mi Chen, Nan Ma. Dual MicroRNA-Triggered Drug Release System for Combined Chemotherapy and Gene Therapy with Logic Operation. ACS Applied Materials & Interfaces 2020, 12 (29) , 32493-32502.
    9. Wei Wei, Jing Sun, Xi-Ying Guo, Xin Chen, Ru Wang, Chong Qiu, Hai-Tao Zhang, Wen-Hao Pang, Jian-Cheng Wang, Qiang Zhang. Microfluidic-Based Holonomic Constraints of siRNA in the Kernel of Lipid/Polymer Hybrid Nanoassemblies for Improving Stable and Safe In Vivo Delivery. ACS Applied Materials & Interfaces 2020, 12 (13) , 14839-14854.
    10. Li-Li Huang, Weidong Nie, Jinfeng Zhang, Hai-Yan Xie. Cell-Membrane-Based Biomimetic Systems with Bioorthogonal Functionalities. Accounts of Chemical Research 2020, 53 (1) , 276-287.
    11. Nourah I. Sabeela, Tahani M. Almutairi, Hamad A. Al-Lohedan, Ayman M. Atta. Surface Activity of Smart Hybrid Polysiloxane-co-N-isopropylacrylamide Microgels. ACS Omega 2019, 4 (25) , 21395-21409.
    12. Ying Chen, Yongchao Yao, Xueying Zhou, Chunyan Liao, Xin Dai, Jie Liu, Yunlong Yu, Shiyong Zhang. Cascade-Reaction-Based Nanodrug for Combined Chemo/Starvation/Chemodynamic Therapy against Multidrug-Resistant Tumors. ACS Applied Materials & Interfaces 2019, 11 (49) , 46112-46123.
    13. Natesan Thirumalaivasan, Parthiban Venkatesan, Ping-Shan Lai, Shu-Pao Wu. In Vitro and In Vivo Approach of Hydrogen-Sulfide-Responsive Drug Release Driven by Azide-Functionalized Mesoporous Silica Nanoparticles. ACS Applied Bio Materials 2019, 2 (9) , 3886-3896.
    14. Yongjuan Li, Juanjuan Dang, Qiujun Liang, Lichen Yin. Thermal-Responsive Carbon Monoxide (CO) Delivery Expedites Metabolic Exhaustion of Cancer Cells toward Reversal of Chemotherapy Resistance. ACS Central Science 2019, 5 (6) , 1044-1058.
    15. Ali Khademhosseini, (Associate Editor), Andre E. Nel, (Associate Editor), Holly Bunje, (ACS Nano Communications), Christopher J. DeSantis, (Managing Editor), Anne M. Andrews, (Professor and ACS Chemical Neuroscience Associate Editor), Rita A. Blaik, (CNSI Manager of Education), Zhen Gu, (Professor), Huan Meng, (Assistant Professor), Aydogan Ozcan, (Chancellor’s Professor and Editorial Advisory Board), Sarah H. Tolbert, (Professor), Tian Xia, (Associate Professor), Jeffrey I. Zink, (Distinguished Professor), Paul S. Weiss (Editor-in-Chief). Nanoscience and Nanotechnology at UCLA. ACS Nano 2019, 13 (6) , 6127-6129.
    16. Wei Chen, Carlotta A. Glackin, Marcus A. Horwitz, Jeffrey I. Zink. Nanomachines and Other Caps on Mesoporous Silica Nanoparticles for Drug Delivery. Accounts of Chemical Research 2019, 52 (6) , 1531-1542.
    17. Ping-Hsing Tsai, Mong-Lien Wang, Jen-Hsuan Chang, Aliaksandr A. Yarmishyn, Phan Nguyen Nhi Nguyen, Wei Chen, Yueh Chien, Teh-Ia Huo, Chung-Yuan Mou, Shih-Hwa Chiou. Dual Delivery of HNF4α and Cisplatin by Mesoporous Silica Nanoparticles Inhibits Cancer Pluripotency and Tumorigenicity in Hepatoma-Derived CD133-Expressing Stem Cells. ACS Applied Materials & Interfaces 2019, 11 (22) , 19808-19818.
    18. Patricia Mora-Raimundo, Daniel Lozano, Miguel Manzano, María Vallet-Regí. Nanoparticles to Knockdown Osteoporosis-Related Gene and Promote Osteogenic Marker Expression for Osteoporosis Treatment. ACS Nano 2019, 13 (5) , 5451-5464.
    19. Shu Wang, Xi Liu, Shizhu Chen, Zhirong Liu, Xiaodi Zhang, Xing-Jie Liang, Linlin Li. Regulation of Ca2+ Signaling for Drug-Resistant Breast Cancer Therapy with Mesoporous Silica Nanocapsule Encapsulated Doxorubicin/siRNA Cocktail. ACS Nano 2019, 13 (1) , 274-283.
    20. Xiangsheng Liu, Jinhong Jiang, Ryan Chan, Ying Ji, Jianqin Lu, Yu-Pei Liao, Michael Okene, Joshua Lin, Paulina Lin, Chong Hyun Chang, Xiang Wang, Ivanna Tang, Emily Zheng, Waveley Qiu, Zev A. Wainberg, Andre E. Nel, Huan Meng. Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer. ACS Nano 2019, 13 (1) , 38-53.
    21. Qing-Shan Pan, Ting-Ting Chen, Cun-Peng Nie, Jin-Tao Yi, Chang Liu, Yan-Lei Hu, Xia Chu. In Situ Synthesis of Ultrathin ZIF-8 Film-Coated MSNs for Codelivering Bcl 2 siRNA and Doxorubicin to Enhance Chemotherapeutic Efficacy in Drug-Resistant Cancer Cells. ACS Applied Materials & Interfaces 2018, 10 (39) , 33070-33077.
    22. Upashi Goswami, Raghuram Kandimalla, Sanjeeb Kalita, Arun Chattopadhyay, Siddhartha Sankar Ghosh. Polyethylene Glycol-Encapsulated Histone Deacetylase Inhibitor Drug-Composite Nanoparticles for Combination Therapy with Artesunate. ACS Omega 2018, 3 (9) , 11504-11516.
    23. Perry T. Yin, Thanapat Pongkulapa, Hyeon-Yeol Cho, Jiyou Han, Nicholas J. Pasquale, Hudifah Rabie, Jong-Hoon Kim, Jeong-Woo Choi, Ki-Bum Lee. Overcoming Chemoresistance in Cancer via Combined MicroRNA Therapeutics with Anticancer Drugs Using Multifunctional Magnetic Core–Shell Nanoparticles. ACS Applied Materials & Interfaces 2018, 10 (32) , 26954-26963.
    24. Wei Ha, Xiao-bo Zhao, Xin-yue Chen, Kan Jiang, Yan-ping Shi. Prodrug-Based Cascade Self-Assembly Strategy for Precisely Controlled Combination Drug Therapy. ACS Applied Materials & Interfaces 2018, 10 (25) , 21149-21159.
    25. Tania Patiño, Natalia Feiner-Gracia, Xavier Arqué, Albert Miguel-López, Anita Jannasch, Tom Stumpp, Erik Schäffer, Lorenzo Albertazzi, Samuel Sánchez. Influence of Enzyme Quantity and Distribution on the Self-Propulsion of Non-Janus Urease-Powered Micromotors. Journal of the American Chemical Society 2018, 140 (25) , 7896-7903.
    26. Bohan Yin, Kin Hei Kelvin Li, Lok Wai Cola Ho, Cecilia Ka Wing Chan, Chung Hang Jonathan Choi. Toward Understanding in Vivo Sequestration of Nanoparticles at the Molecular Level. ACS Nano 2018, 12 (3) , 2088-2093.
    27. Wei Wang, Kerong Chen, Yujie Su, Jielei Zhang, Min Li, and Jianping Zhou . Lysosome-Independent Intracellular Drug/Gene Codelivery by Lipoprotein-Derived Nanovector for Synergistic Apoptosis-Inducing Cancer-Targeted Therapy. Biomacromolecules 2018, 19 (2) , 438-448.
    28. Ming Zhang, Wentao Wang, Yingjun Cui, Ninglin Zhou, and Jian Shen . Magnetofluorescent Carbon Quantum Dot Decorated Multiwalled Carbon Nanotubes for Dual-Modal Targeted Imaging in Chemo-Photothermal Synergistic Therapy. ACS Biomaterials Science & Engineering 2018, 4 (1) , 151-162.
    29. Shudi Yang, Zhaoxiang Ren, Mengtian Chen, Ying Wang, Bengang You, Weiliang Chen, Chenxi Qu, Yang Liu, and Xuenong Zhang . Nucleolin-Targeting AS1411-Aptamer-Modified Graft Polymeric Micelle with Dual pH/Redox Sensitivity Designed To Enhance Tumor Therapy through the Codelivery of Doxorubicin/TLR4 siRNA and Suppression of Invasion. Molecular Pharmaceutics 2018, 15 (1) , 314-325.
    30. Caiyan Zhao, Leihou Shao, Jianqing Lu, Xiongwei Deng, Yujia Tong, and Yan Wu . Hybrid Prodrug Nanoparticles with Tumor Penetration and Programmed Drug Activation for Enhanced Chemoresistant Cancer Therapy. ACS Applied Materials & Interfaces 2017, 9 (22) , 18450-18461.
    31. Yumin Zhang, Fan Huang, Chunhua Ren, Lijun Yang, Jianfeng Liu, Zhen Cheng, Liping Chu, and Jinjian Liu . Targeted Chemo-Photodynamic Combination Platform Based on the DOX Prodrug Nanoparticles for Enhanced Cancer Therapy. ACS Applied Materials & Interfaces 2017, 9 (15) , 13016-13028.
    32. Rajendra K. Singh, Kapil D. Patel, Kam W. Leong, and Hae-Won Kim . Progress in Nanotheranostics Based on Mesoporous Silica Nanomaterial Platforms. ACS Applied Materials & Interfaces 2017, 9 (12) , 10309-10337.
    33. Haihua Xiao, Ruogu Qi, Ting Li, Samuel G. Awuah, Yaorong Zheng, Wei Wei, Xiang Kang, Haiqin Song, Yongheng Wang, Yingjie Yu, Molly A. Bird, Xiabin Jing, Michael B. Yaffe, Michael J. Birrer, and P. Peter Ghoroghchian . Maximizing Synergistic Activity When Combining RNAi and Platinum-Based Anticancer Agents. Journal of the American Chemical Society 2017, 139 (8) , 3033-3044.
    34. Yachao Li, Xianghui Xu, Xiao Zhang, Yunkun Li, Zhijun Zhang, and Zhongwei Gu . Tumor-Specific Multiple Stimuli-Activated Dendrimeric Nanoassemblies with Metabolic Blockade Surmount Chemotherapy Resistance. ACS Nano 2017, 11 (1) , 416-429.
    35. Leihou Shao, Ruirui Zhang, Jianqing Lu, Caiyan Zhao, Xiongwei Deng, and Yan Wu . Mesoporous Silica Coated Polydopamine Functionalized Reduced Graphene Oxide for Synergistic Targeted Chemo-Photothermal Therapy. ACS Applied Materials & Interfaces 2017, 9 (2) , 1226-1236.
    36. Kai Han, Jing-Yi Zhu, Hui-Zhen Jia, Shi-Bo Wang, Shi-Ying Li, Xian-Zheng Zhang, and He-You Han . Mitochondria-Targeted Chimeric Peptide for Trinitarian Overcoming of Drug Resistance. ACS Applied Materials & Interfaces 2016, 8 (38) , 25060-25068.
    37. Jonathan C. Barnes, Peter M. Bruno, Hung V.-T. Nguyen, Longyan Liao, Jenny Liu, Michael T. Hemann, and Jeremiah A. Johnson . Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low Toxicity. Journal of the American Chemical Society 2016, 138 (38) , 12494-12501.
    38. Xiangsheng Liu, Allen Situ, Yanan Kang, Katie Rose Villabroza, Yupei Liao, Chong Hyun Chang, Timothy Donahue, Andre E. Nel, and Huan Meng . Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer. ACS Nano 2016, 10 (2) , 2702-2715.
    39. Elena Aznar, Mar Oroval, Lluís Pascual, Jose Ramón Murguía, Ramón Martínez-Máñez, and Félix Sancenón . Gated Materials for On-Command Release of Guest Molecules. Chemical Reviews 2016, 116 (2) , 561-718.
    40. Meng Huang, Meng Hu, Qingxiang Song, Huahua Song, Jialin Huang, Xiao Gu, Xiaolin Wang, Jun Chen, Ting Kang, Xingye Feng, Di Jiang, Gang Zheng, Hongzhuan Chen, and Xiaoling Gao . GM1-Modified Lipoprotein-like Nanoparticle: Multifunctional Nanoplatform for the Combination Therapy of Alzheimer’s Disease. ACS Nano 2015, 9 (11) , 10801-10816.
    41. Ulrich Lächelt and Ernst Wagner . Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond). Chemical Reviews 2015, 115 (19) , 11043-11078.
    42. Bin Yang, Xing Dong, Qi Lei, Renxi Zhuo, Jun Feng, and Xianzheng Zhang . Host–Guest Interaction-Based Self-Engineering of Nano-Sized Vesicles for Co-Delivery of Genes and Anticancer Drugs. ACS Applied Materials & Interfaces 2015, 7 (39) , 22084-22094.
    43. Huan Meng, Meiying Wang, Huiyu Liu, Xiangsheng Liu, Allen Situ, Bobby Wu, Zhaoxia Ji, Chong Hyun Chang, and Andre E. Nel . Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice. ACS Nano 2015, 9 (4) , 3540-3557.
    44. Liangliang Dai, Qingfeng Zhang, Jinghua Li, Xinkun Shen, Caiyun Mu, and Kaiyong Cai . Dendrimerlike Mesoporous Silica Nanoparticles as pH-Responsive Nanocontainers for Targeted Drug Delivery and Bioimaging. ACS Applied Materials & Interfaces 2015, 7 (13) , 7357-7372.
    45. Liming Wang, Qiang Sun, Xin Wang, Tao Wen, Jun-Jie Yin, Pengyang Wang, Ru Bai, Xiang-Qian Zhang, Lu-Hua Zhang, An-Hui Lu, and Chunying Chen . Using Hollow Carbon Nanospheres as a Light-Induced Free Radical Generator To Overcome Chemotherapy Resistance. Journal of the American Chemical Society 2015, 137 (5) , 1947-1955.
    46. Qing-Lan Li, Yanfang Sun, Yu-Long Sun, Jijie Wen, Yue Zhou, Qi-Ming Bing, Lyle D. Isaacs, Yinghua Jin, Hui Gao, and Ying-Wei Yang . Mesoporous Silica Nanoparticles Coated by Layer-by-Layer Self-assembly Using Cucurbit[7]uril for in Vitro and in Vivo Anticancer Drug Release. Chemistry of Materials 2014, 26 (22) , 6418-6431.
    47. Xiaoxi Huang, Zhimin Tao, John C. Praskavich, Jr., Anandarup Goswami, Jafar F. Al-Sharab, Tamara Minko, Vivek Polshettiwar, and Tewodros Asefa . Dendritic Silica Nanomaterials (KCC-1) with Fibrous Pore Structure Possess High DNA Adsorption Capacity and Effectively Deliver Genes In Vitro. Langmuir 2014, 30 (36) , 10886-10898.
    48. Yu Chen, Hangrong Chen, and Jianlin Shi . Inorganic Nanoparticle-Based Drug Codelivery Nanosystems To Overcome the Multidrug Resistance of Cancer Cells. Molecular Pharmaceutics 2014, 11 (8) , 2495-2510.
    49. Tan-Boon Toh, Dong-Keun Lee, Weixin Hou, Lissa Nurrul Abdullah, Jacqueline Nguyen, Dean Ho, and Edward Kai-Hua Chow . Nanodiamond–Mitoxantrone Complexes Enhance Drug Retention in Chemoresistant Breast Cancer Cells. Molecular Pharmaceutics 2014, 11 (8) , 2683-2691.
    50. Anish Babu, Qi Wang, Ranganayaki Muralidharan, Manish Shanker, Anupama Munshi, and Rajagopal Ramesh . Chitosan Coated Polylactic Acid Nanoparticle-Mediated Combinatorial Delivery of Cisplatin and siRNA/Plasmid DNA Chemosensitizes Cisplatin-Resistant Human Ovarian Cancer Cells. Molecular Pharmaceutics 2014, 11 (8) , 2720-2733.
    51. Liangliang Dai, Jinghua Li, Beilu Zhang, Junjie Liu, Zhong Luo, and Kaiyong Cai . Redox-Responsive Nanocarrier Based on Heparin End-Capped Mesoporous Silica Nanoparticles for Targeted Tumor Therapy in Vitro and in Vivo. Langmuir 2014, 30 (26) , 7867-7877.
    52. Christian Argyo, Veronika Weiss, Christoph Bräuchle, and Thomas Bein . Multifunctional Mesoporous Silica Nanoparticles as a Universal Platform for Drug Delivery. Chemistry of Materials 2014, 26 (1) , 435-451.
    53. Cuichen Wu, Da Han, Tao Chen, Lu Peng, Guizhi Zhu, Mingxu You, Liping Qiu, Kwame Sefah, Xiaobing Zhang, and Weihong Tan . Building a Multifunctional Aptamer-Based DNA Nanoassembly for Targeted Cancer Therapy. Journal of the American Chemical Society 2013, 135 (49) , 18644-18650.
    54. Huan Meng, Yang Zhao, Juyao Dong, Min Xue, Yu-Shen Lin, Zhaoxia Ji, Wilson X. Mai, Haiyuan Zhang, Chong Hyun Chang, C. Jeffrey Brinker, Jeffrey I. Zink, and Andre E. Nel . Two-Wave Nanotherapy To Target the Stroma and Optimize Gemcitabine Delivery To a Human Pancreatic Cancer Model in Mice. ACS Nano 2013, 7 (11) , 10048-10065.
    55. Zhong Luo, Xingwei Ding, Yan Hu, Shaojue Wu, Yang Xiang, Yongfei Zeng, Beilu Zhang, Hong Yan, Huacheng Zhang, Liangliang Zhu, Junjie Liu, Jinghua Li, Kaiyong Cai, and Yanli Zhao . Engineering a Hollow Nanocontainer Platform with Multifunctional Molecular Machines for Tumor-Targeted Therapy in Vitro and in Vivo. ACS Nano 2013, 7 (11) , 10271-10284.
    56. Zhou J. Deng, Stephen W. Morton, Elana Ben-Akiva, Erik C. Dreaden, Kevin E. Shopsowitz, and Paula T. Hammond . Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment. ACS Nano 2013, 7 (11) , 9571-9584.
    57. Yan Yan, Mattias Björnmalm, and Frank Caruso . Particle Carriers for Combating Multidrug-Resistant Cancer. ACS Nano 2013, 7 (11) , 9512-9517.
    58. Shubham Mehta, Vraj Shah, Gautam Patel, Carlos Adam Conte-Junior, Nirav Joshi. A holistic review of recent advances in nano-based drug delivery systems for the treatment of triple-negative breast cancer (TNBC). Journal of Nanoparticle Research 2024, 26 (5)
    59. Twan Lammers. Nanomedicine Tumor Targeting. Advanced Materials 2024, 46
    60. Xiaohong Wen, Zhixiang Huang, Xiaohai Yang, Xiaoxiao He, Lie Li, Haiyan Chen, Kemin Wang, Qiuping Guo, Jianbo Liu. Development of an aptamer capable of multidrug resistance reversal for tumor combination chemotherapy. Proceedings of the National Academy of Sciences 2024, 121 (15)
    61. Chengbin Yang, Zheng‐Ian Lin, Xinmeng Zhang, Zhourui Xu, Gaixia Xu, Yu‐Min Wang, Tzu‐Hsien Tsai, Pei‐Wen Cheng, Wing‐Cheung Law, Ken‐Tye Yong, Chih‐Kuang Chen. Recent Advances in Engineering Carriers for siRNA Delivery. Macromolecular Bioscience 2024, 24 (4)
    62. Zhengfa Jiang, Zongmian Song, Chen Cao, Miaoheng Yan, Zhendong Liu, Xingbo Cheng, Hongbo Wang, Qingnan Wang, Hongjian Liu, Songfeng Chen. Multiple Natural Polymers in Drug and Gene Delivery Systems. Current Medicinal Chemistry 2024, 31 (13) , 1691-1715.
    63. Jingting Wu, Xiaoqi Zheng, Wenqing Lin, Linhuan Chen, Zai‐Sheng Wu. Persistent Targeting DNA Nanocarrier Made of 3D Structural Unit Assembled from Only One Basic Multi‐Palindromic Oligonucleotide for Precise Gene Cancer Therapy. Advanced Healthcare Materials 2024, 13 (11)
    64. Juanjuan Dang, Yongjuan Li, Jing Yan, Jianhua Wu, Kaimin Cai, Lichen Yin, Zhuchao Zhou. Reversal of Chemoresistance via Staged Liberation of Chemodrug and siRNA in Hierarchical Response to ROS Gradient. Advanced Healthcare Materials 2024, 575
    65. Ashutosh Gupta, Kumar Nishchaya, Moumita Saha, Gaurisha Alias Resha Ramnath Naik, Sarika Yadav, Shreya Srivastava, Amrita Arup Roy, Sudheer Moorkoth, Srinivas Mutalik, Namdev Dhas. Recent advancements in nanoconstructs for the theranostics applications for triple negative breast cancer. Journal of Drug Delivery Science and Technology 2024, 93 , 105401.
    66. Mahfoozur Rahman, Obaid Afzal, Shehla Nasar Mir Najib Ullah, Mohammad Y. Alshahrani, Ali G. Alkhathami, Ankit Sahoo, Abdulmalik Saleh Alfawaz Altamimi, Waleed H. Almalki, Salem Salman Almujri, Alhamyani abdulrahman, Aryam Riyadh Abdullah Alotaibi, Manal A. Alossaimi, Tanuja Singh, Sarwar Beg. Nanocarriers for delivering nucleic acids and chemotherapeutic agents as combinational approach: Challenges, clinical progress, and unmet needs. Journal of Drug Delivery Science and Technology 2024, 92 , 105326.
    67. Yufan Xiang, Zhiqian Li, Dayi Pan, Qiyong Gong, Kui Luo, Yanhui Liu. Challenges and Opportunities of Nanomedicine: Novel Comprehensive Approaches for Brain Metastasis. Small Structures 2024, 5 (2)
    68. Mohamed El-Tanani, Hamdi Nsairat, Alaa A Aljabali, Ismail I. Matalka, Alaaldin M. Alkilany, Murtaza M Tambuwala. Dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer. Expert Opinion on Drug Delivery 2024, 2
    69. Pedram Ebrahimnejad, Zahra Mohammadi, Amirhossein Babaei, Melika Ahmadi, Shervin Amirkhanloo, Kofi Asare-Addo, Ali Nokhodchid. Novel Strategies Using Sagacious Targeting for Site-Specific Drug Delivery in Breast Cancer Treatment: Clinical Potential and Applications. Critical Reviews™ in Therapeutic Drug Carrier Systems 2024, 41 (1) , 35-84.
    70. Aslı Sade Memişoğlu, Zehra Tavşan. Nanomedicine Based Therapies Against Cancer Stem Cells. 2023, 239-273.
    71. Xiangyi Kong, Peng Gao, Jing Wang, Yi Fang, Kuo Chu Hwang. Advances of medical nanorobots for future cancer treatments. Journal of Hematology & Oncology 2023, 16 (1)
    72. Sharon Rose Pamshong, Dhananjay Bhatane, Santosh Sarnaik, Amit Alexander. Mesoporous silica nanoparticles: An emerging approach in overcoming the challenges with oral delivery of proteins and peptides. Colloids and Surfaces B: Biointerfaces 2023, 232 , 113613.
    73. Bolong Xu, Shanshan Li, Rui Shi, Huiyu Liu. Multifunctional mesoporous silica nanoparticles for biomedical applications. Signal Transduction and Targeted Therapy 2023, 8 (1)
    74. Razieh Heidari, Vahideh Assadollahi, Pegah Khosravian, Seyed Abbas Mirzaei, Fatemeh Elahian. Engineered mesoporous silica nanoparticles, new insight nanoplatforms into effective cancer gene therapy. International Journal of Biological Macromolecules 2023, 253 , 127060.
    75. Muhammad Usman Akbar, Arslan Akbar, Umair Ali Khan Saddozai, Malik Ihsan Ullah Khan, Muhammad Zaheer, Muhammad Badar. A multivariate metal–organic framework based pH-responsive dual-drug delivery system for chemotherapy and chemodynamic therapy. Materials Advances 2023, 4 (22) , 5653-5667.
    76. Eliska Prchalova, Zuzana Kohoutova, Karolina Knittelova, David Malinak, Kamil Musilek. Strategies for enhanced bioavailability of oxime reactivators in the central nervous system. Archives of Toxicology 2023, 97 (11) , 2839-2860.
    77. Wojciech Szymanowski, Anna Szymanowska, Anna Bielawska, Gabriel Lopez-Berestein, Cristian Rodriguez-Aguayo, Paola Amero. Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges. Cancers 2023, 15 (21) , 5300.
    78. Arti Shettiwar, Ujala Gupta, Priti Paul, Rahul Nair, Mayur Aalhate, Srushti Mahajan, Indrani Maji, Santosh Kumar Guru, Neelesh Kumar Mehra, Pankaj Kumar Singh. A comprehensive review of the biomaterial-based multifunctional nanocarriers for therapeutic applications in breast cancer. Journal of Drug Delivery Science and Technology 2023, 89 , 104990.
    79. Meng‐Zhen Yu, Nan‐Nan Wang, Jia‐Qing Zhu, Yao‐Xin Lin. The clinical progress and challenges of mRNA vaccines. WIREs Nanomedicine and Nanobiotechnology 2023, 15 (5)
    80. Humayra Afrin, Renu Geetha Bai, Raj Kumar, Sheikh Shafin Ahmad, Sandeep K. Agarwal, Md Nurunnabi. Oral delivery of RNAi for cancer therapy. Cancer and Metastasis Reviews 2023, 42 (3) , 699-724.
    81. Han Han, Lei Xing, Bi-Te Chen, Yang Liu, Tian-Jiao Zhou, Yi Wang, Ling-Feng Zhang, Ling Li, Chong-Su Cho, Hu-Lin Jiang. Progress on the pathological tissue microenvironment barrier-modulated nanomedicine. Advanced Drug Delivery Reviews 2023, 200 , 115051.
    82. Yan-Ni Bao, Xiu-Li Xie, Li-Li Lu, Wen-Hao Liu, Yu-Chen Ma, Yi-Jun Ke, Huan Ren, Li-Na Tan, Li-Fang Wu, Jue Song, Yong Jin, Xiao-Yan Liu. NiFe-layered double hydroxide nanoparticle for co-delivery of DOX and siRNA to overcome multidrug resistance in MCF-7/ADR cells. Journal of Drug Delivery Science and Technology 2023, 87 , 104829.
    83. Sumel Ashique, Ashish Garg, Afzal Hussain, Arshad Farid, Prashant Kumar, Farzad Taghizadeh‐Hesary. Nanodelivery systems: An efficient and target‐specific approach for drug‐resistant cancers. Cancer Medicine 2023, 12 (18) , 18797-18825.
    84. Pengxuan Zhao, Yeteng Zhong, Pengcheng Pan, Shasha Zhang, Yu Tian, Jun Zhang, Guohui Yi, Zhendong Zhao, Tiantian Wu. DNA self-assembly nanoflower reverse P-glycoprotein mediated drug resistance in chronic myelogenous leukemia therapy. Frontiers in Bioengineering and Biotechnology 2023, 11
    85. Wenpeng Yu, Xiaowei Zhu, Jichun Liu, Jianliang Zhou. Biofunctionalized Decellularized Tissue-Engineered Heart Valve with Mesoporous Silica Nanoparticles for Controlled Release of VEGF and RunX2-siRNA against Calcification. Bioengineering 2023, 10 (7) , 859.
    86. Jianing Gong, Taoran Shi, Jinfeng Liu, Zerong Pei, Jingbo Liu, Xiaoliang Ren, Fengyun Li, Feng Qiu. Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance. Biomedicine & Pharmacotherapy 2023, 161 , 114505.
    87. Nisar Ul Khaliq, Juyeon Lee, Joohyeon Kim, Yejin Kim, Sohyeon Yu, Jisu Kim, Sangwoo Kim, Daekyung Sung, Hyungjun Kim. Mesoporous Silica Nanoparticles as a Gene Delivery Platform for Cancer Therapy. Pharmaceutics 2023, 15 (5) , 1432.
    88. Jiali Cai, Shuqi Jiang, Jingtong Liao, Huiping Fan, Chen Peng, Shenghong Shi, Shengfeng Huang, Guochuang Chen, Junyao Xu, Zhiyong Wang. Manganese-doped biostimulatory nanoneedle for MRI-visual bispecific antibody gene delivery and immunosuppression reversal as a cancer immunotherapy strategy. Chemical Engineering Journal 2023, 462 , 142242.
    89. Cristina de la Torre, Carmen Coll, Amelia Ultimo, Félix Sancenón, Ramón Martínez-Máñez, Eduardo Ruiz-Hernández. In Situ-Forming Gels Loaded with Stimuli-Responsive Gated Mesoporous Silica Nanoparticles for Local Sustained Drug Delivery. Pharmaceutics 2023, 15 (4) , 1071.
    90. Patrícia V. Teixeira, Eduarda Fernandes, Telma B. Soares, Filomena Adega, Carla M. Lopes, Marlene Lúcio. Natural Compounds: Co-Delivery Strategies with Chemotherapeutic Agents or Nucleic Acids Using Lipid-Based Nanocarriers. Pharmaceutics 2023, 15 (4) , 1317.
    91. Qing Li, Yuefei Wang, Gong Zhang, Rongxin Su, Wei Qi. Biomimetic mineralization based on self-assembling peptides. Chemical Society Reviews 2023, 52 (5) , 1549-1590.
    92. Liang-Hsin Chen, Nai-Wen Liang, Wei-Yuan Huang, Yu-Chung Liu, Chia-Yu Ho, Chen-Hsiang Kuan, Yu-Fen Huang, Tzu-Wei Wang. Supramolecular hydrogel for programmable delivery of therapeutics to cancer multidrug resistance. Biomaterials Advances 2023, 146 , 213282.
    93. Elena Boggio, Casimiro Luca Gigliotti, Ian Stoppa, Deepika Pantham, Sara Sacchetti, Roberta Rolla, Margherita Grattarola, Chiara Monge, Stefania Pizzimenti, Umberto Dianzani, Chiara Dianzani, Luigi Battaglia. Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications. Pharmaceutics 2023, 15 (3) , 937.
    94. Pramod Kumar, Rajesh Salve, Kishore M. Paknikar, Virendra Gajbhiye. Nucleolin aptamer conjugated MSNPs-PLR-PEG multifunctional nanoconstructs for targeted co-delivery of anticancer drug and siRNA to counter drug resistance in TNBC. International Journal of Biological Macromolecules 2023, 229 , 600-614.
    95. Bhagavathi Sivamaruthi, Subramanian Thangaleela, Periyanaina Kesika, Natarajan Suganthy, Chaiyavat Chaiyasut. Mesoporous Silica-Based Nanoplatforms Are Theranostic Agents for the Treatment of Inflammatory Disorders. Pharmaceutics 2023, 15 (2) , 439.
    96. Shanshan Liu, Jianfeng Wang, Haiguang Li, Chen Xu, Yimin Guo, Xiaotong Bao, Shaokang Guan, Hairong Liu, Tao Zhang. Nucleus‐Targeting Carbon Quantum Dots Assembled with Gambogic Acid via π–π Stacking for Cancer Therapy. Advanced Therapeutics 2023, 6 (1)
    97. Tamil Selvan Subramanian. Cancer Nanomedicine. 2023, 17-31.
    98. Hongyan Liu, Xialin Zhu, Yuyan Wei, Chunhong Song, Yunshan Wang. Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems. Biomedicine & Pharmacotherapy 2023, 157 , 114065.
    99. Yu Hsia, Maharajan Sivasubramanian, Chia-Hui Chu, Yao-Chen Chuang, Yiu-Kay Lai, Leu-Wei Lo. A Dual Concentration-Tailored Cytokine-Chemo Nanosystem to Alleviate Multidrug Resistance and Redirect Balance of Cancer Proliferation and Apoptosis. International Journal of Nanomedicine 2023, Volume 18 , 4253-4274.
    100. Zahra Shakeran, Jaleh Varshosaz, Mehrnaz Keyhanfar, Hossein Mohammad-Beigi, Karim Rahimi, Duncan S. Sutherland. Co-delivery of STAT3 siRNA and methotrexate in breast cancer cells. Artificial Cells, Nanomedicine, and Biotechnology 2022, 50 (1) , 29-39.
    Load more citations

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Your Mendeley pairing has expired. Please reconnect